Advanced Search

 

Study ID Status Title Patient Level Data
203158 Recruiting Exploration of the peripheral immune system in subjects with New Onset T1 Diabetes (NOT1D)
203160 Completed Clinical Evaluation of Oral Hygiene Products in an In Situ Caries Model
203161 Withdrawn Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries Model
203162 Recruiting An escalating dose, randomized, placebo-controlled, incomplete-block, 2-period cross-over study to assess the dose response for topical efficacy via airway responsiveness to adenosine-5'-monophosphate (AMP) challenge and the dose response for systemic activity via 24 hour (h) plasma cortisol suppression and thereby the relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects
203167 Recruiting A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled, repeat dose study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with active plaque-type psoriasis
203168 Recruiting A multicenter, randomized, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with moderate to severe rheumatoid arthritis
203818 Recruiting A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren’s Syndrome
203820 Completed A two-part trial to evaluate the safety, tolerability, clinical effect and systemic exposure potential of topically applied GSK2981278 ointment in subjects with plaque psoriasis
203821 Completed Summary Document Analysis Plan for the Meta-Analysis and Assessment of Serious Event Outcomes in Patients with Persistent Asthma Receiving Salmeterol in Combination with Fluticasone as ADVAIR
204471 Completed A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab to mepolizumab 100mg subcutaneous (study number 204471- the OSMO study)
204476 Not yet recruiting Impact of a multiple micronutrient (MMN) beverage powder on vaccine response in school children (7-10yrs; inclusive) in Bangladesh: a randomised, double blind controlled trial
204477 Recruiting Clinical study to measure the impact of fortified malt based food on immunity outcomes in school children
204485 Active, Not Recruiting Epidemiological study Assessing the Burden of Illness Related to Severe Asthma in Quebec
204486 Recruiting Cross-vaccination study of GSK Biologicals’ Lyophilized formulation of the Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) in subjects who previously received placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) studies
204499 Not yet recruiting A Multicentre Observational Study with 90-days Follow-up Period to Evaluate Clinical Practice Variability as well as Clinical and Organisational Factors Related to Outcomes for COPD Hospital Admissions in Portugal
204500 Active, Not Recruiting Salford Lung Studies: Follow-up Interviews on Patient-Centred Outcomes
204503 Terminated Assessment of cognitive function and mobility in individuals with pain
204509 Completed A single-centre, follow-up study to investigate the effect of GSK2245035 on nasal allergic reactivity in subjects who completed treatment in study TL7116958 in 2014
204511 Recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of ANORO administered in Korean subjects with chronic obstructive pulmonary disease (COPD) in usual practice
204516 Completed An Exploratory Study to Assess Two Accelerated Models of Barrier Repair
204521 Not yet recruiting Meta-analysis of Arnuity (FF) studies FFA109685 & FFA112059 Direct comparison of FF100 QD and FP 250 BD for Trough FEV1
204524 Active, Not Recruiting Nucala® Subcutaneous Injection Special Drug Use Investigation (Long-Term)
204645 Recruiting Seasonal Allergic Rhinitis Symptom Severity Observational Study
204646 Completed Bioequivalence Study of Dutasteride Capsules-An evaluation of the bioequivalence of dutasteride capsule manufactured at GSK compared to dutasteride capsule manufactured at Catalent in healthy Japanese male subjects Study Listed on ClinicalStudyDataRequest.com
204653 Recruiting A phase I, open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin’s lymphoma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.